A Novel Approach to Brachial Plexus Catheter Management: A Brachial Plexus Test Dose for Phrenic Nerve Paralysis and Patient-Controlled, Demand-Only Dosing for a Patient With Extreme Obesity

A A Case Rep. 2016 Sep 15;7(6):139-42. doi: 10.1213/XAA.0000000000000369.

Abstract

A 53-year-old woman with extreme obesity (body mass index = 82 kg/m) presented for an open reduction and internal fixation of the proximal humerus. This report describes the novel management of her continuous brachial plexus catheter in the setting of her comorbidities. Phrenic nerve paralysis from brachial plexus blocks can cause clinically significant dyspnea in obese patients. Brachial plexus catheters can be used effectively for these patients with some modification to routine management. We detail our use of a short-acting chloroprocaine test dose for phrenic paralysis and demand-only dosing to provide effective analgesia while avoiding respiratory complications associated with these blocks.

Publication types

  • Case Reports

MeSH terms

  • Analgesia, Patient-Controlled / adverse effects
  • Analgesia, Patient-Controlled / methods*
  • Autonomic Nerve Block / adverse effects
  • Autonomic Nerve Block / methods*
  • Brachial Plexus / diagnostic imaging*
  • Catheterization / methods
  • Female
  • Humans
  • Middle Aged
  • Obesity / complications
  • Obesity / diagnostic imaging*
  • Phrenic Nerve / diagnostic imaging*
  • Respiratory Paralysis / diagnostic imaging*
  • Respiratory Paralysis / etiology